Browse the corpus

REFERENCES Bidstrup BP, Royston D, Sapsford RN, et al, “Reduction in Blood Loss and Blood Use After Cardiovascular Bypass With High Dose Aprotinin,” J Thorac Cardiovasc Surg , 1989, 97(3):364-72. [PubMed 2465457 ] Boldt J, “Endothelial-Related Coagulation in Pediatric Surgery,” Ann Thorac Surg , 1998, 65(6 Suppl):56-9. Carrel TP, Schwanda M, Vogt P, et al, “Aprotinin in Pediatric Cardiac Operations: A Benefit in Complex Malformations and With High-Dose Regimen Only,” Ann Thorac Surg , 1998, 66(1):153-8. [PubMed 9692456 ] Cosgrove DM 3d, Heric B, Lytle BW, et al, “Aprotinin Therapy for Reoperative Myocardial Revascularization: A Placebo-Controlled Study,” Ann Thorac Surg , 1992, 54(6):1031-6. [PubMed 1280411 ] Engles L, “Review and Application of Serine Protease Inhibition in Coronary Artery Bypass Graft Surgery,” Am J Health Syst Pharm , 2005, 62(18 Suppl 4):9-14. Fergusson DA, Hebert PC, Mazer CD, et al, “A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery,” N Engl J Med , 2008, 358(22):2319-31. [PubMed 18480196 ] Hess PJ Jr, “Systemic Inflammatory Response to Coronary Artery Bypass Graft Surgery,” Am J Health Syst Pharm , 2005, 62(18 Suppl 4):6-9. Huang H, Ding W, Su Z, et al, “Mechanism of the Preserving Effect of Aprotinin on Platelet Function and Its Use in Cardiac Surgery,” J Thorac Cardiovasc Surg , 1993, 106(1):11-8. [PubMed 7686594 ] Karkouti K, Cohen MM, McCluskey SA, et al, “A Multivariable Model For Predicting The Need For Blood Transfusion In Patients Undergoing First-Time Elective Coronary Bypass Graft Surgery,” Transfusion , 2001, 41(10):1193-1203. [PubMed 11606816 ] Mangano DT, Tudor IC, and Dietzel C (for the Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation), “The Risk Associated With Aprotinin in Cardiac Surgery,” N Engl J Med , 2006, 354(4):353-65. [PubMed 16436767 ] Mangano DT, Miao Y, Vuylsteke A, et al, “Mortality Associated With Aprotinin During 5 Years Following Coronary Artery Bypass Graft Surgery,” JAMA , 2007, 297(5):471-9. [PubMed 17284697 ] Miller BE, Tosone SR, Tam VK, et al, “Hematologic and Economic Impact of Aprotinin in Reoperative Pediatric Cardiac Operations,” Ann Thorac Surg , 1998, 66(2):535-41. [PubMed 9725399 ] Penkoske P, Entwistle LM, Marchak BE, et al, “Aprotinin in Children Undergoing Repair of Congenital Heart Defects,” Ann Thorac Surg , 1995, 60(6 Suppl):529-32.

Miller BE, Tosone SR, Tam VK, et al, “Hematologic and Economic Impact of Aprotinin in Reoperative Pediatric Cardiac Operations,” Ann Thorac Surg , 1998, 66(2):535-41. [PubMed 9725399 ] Penkoske P, Entwistle LM, Marchak BE, et al, “Aprotinin in Children Undergoing Repair of Congenital Heart Defects,” Ann Thorac Surg , 1995, 60(6 Suppl):529-32. Schulze K, Graeter T, Schaps D, et al, “Severe Anaphylactic Shock Due to Repeated Application of Aprotinin in Patients Following Intrathoracic Aortic Replacement,” Eur J Cardiothorac Surg , 1993, 7(9):495-6. [PubMed 7692900 ] Spray TL, “Use of Aprotinin in Pediatric Organ Transplantation,” Ann Thorac Surg , 1998, 65(6 Suppl):71-3. Verstraete M, “Clinical Application of Inhibitors of Fibrinolysis,” Drugs , 1985, 29(3):236-61. [PubMed 2580684 ] Viby-Mogensen J, “Interaction of Other Drugs With Muscle Relaxants,” Semin Anesth , 1985, 4:52-64. Woodman RC and Harker LA, “Bleeding Complications Associated With Cardiopulmonary Bypass,” Blood , 1990, 76(9):1680-97. [PubMed 2224118 ] Topic 8875 Version 34.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1103-89.32.226.102-36135ECCB4-S244013.14]